This department is offering a grant opportunity to accelerate the development of medications for treating Substance-Use Disorders (SUDs). The grant aims to support preclinical and/or clinical research projects focused on medication studies with high impact to advance treatments closer to FDA approval. Projects funded under this opportunity are expected to be large-scale, short-term cooperative agreements with up to $5 million in annual funding for a duration of up to 3 years. Research applications will involve significant scientific collaboration and monitoring by NIDA staff, enabling critical medications development studies that go beyond traditional R01 grants.
Opportunity ID: 298907
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-219 |
| Funding Opportunity Title: | Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 21, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jul 25, 2019 |
| Current Closing Date for Applications: | Jul 25, 2019 |
| Archive Date: | Aug 30, 2019 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $5,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses State governments Private institutions of higher education Public and State controlled institutions of higher education County governments City or township governments Public housing authorities/Indian housing authorities For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of medication for the treatment of Substance-Use Disorders (SUDs) by encouraging research applications to support a diverse array of preclinical and/or clinical research projects. The goal is to fund medication studies that will have high impact and quickly yield the necessary results to advance medications closer to FDA approval. It is expected that these U01s will be short-term (funded for up to 3 years) and large (up to $5 million per year) cooperative agreements with close monitoring and significant scientific involvement of NIDA staff. This funding opportunity will enable critical medications development studies that would not be feasible using the traditional R01 activity code. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-219.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or after January 25, 2018 | PKG00236471 | Feb 25, 2018 | Jul 25, 2019 | View |
Package 1
Mandatory forms
298907 RR_SF424_2_0-2.0.pdf
298907 PHS398_CoverPageSupplement_4_0-4.0.pdf
298907 RR_OtherProjectInfo_1_4-1.4.pdf
298907 PerformanceSite_2_0-2.0.pdf
298907 RR_KeyPersonExpanded_2_0-2.0.pdf
298907 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
298907 RR_Budget_1_4-1.4.pdf
298907 RR_SubawardBudget30_1_4-1.4.pdf
298907 PHS398_ModularBudget_1_2-1.2.pdf
298907 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
